Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.294
-0.018 (-5.67%)
At close: Dec 20, 2024, 4:00 PM
0.260
-0.034 (-11.68%)
After-hours: Dec 20, 2024, 7:59 PM EST
Petros Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -4.73 | -8.16 | -20.04 | -8.99 | -20.59 | -32.51 | |
| Depreciation & Amortization | 3.11 | 3.42 | 5.72 | 6.88 | 6.66 | 5.29 | |
| Other Amortization | - | - | - | 0.01 | 0.04 | 4.67 | |
| Asset Writedown & Restructuring Costs | - | - | 7.46 | - | - | 2.44 | |
| Stock-Based Compensation | 0.68 | 0.42 | 1.2 | 1.31 | - | - | |
| Provision & Write-off of Bad Debts | 0.01 | 0.03 | -0.17 | 0.15 | 0.2 | -0.03 | |
| Other Operating Activities | -8.95 | -3.95 | -3.87 | -9.46 | 3.98 | 9.57 | |
| Change in Accounts Receivable | 1.01 | -0.14 | 0.52 | 2.55 | -2.75 | 0.93 | |
| Change in Inventory | -1.07 | -0.91 | -0.84 | 0.41 | 0.73 | 2.56 | |
| Change in Accounts Payable | 0.25 | -0.09 | -2.75 | -1.05 | 2.22 | 2.02 | |
| Change in Unearned Revenue | 0.07 | -0.16 | 0.21 | - | - | - | |
| Change in Other Net Operating Assets | 3.79 | 1.94 | -0.23 | -3.67 | -5.8 | 7.58 | |
| Operating Cash Flow | -5.83 | -7.63 | -12.8 | -11.86 | -15.31 | 2.53 | |
| Operating Cash Flow Growth | - | - | - | - | - | -68.43% | |
| Capital Expenditures | -0.02 | - | - | - | -0 | -0.07 | |
| Investing Cash Flow | -0.02 | - | - | - | -0 | -0.07 | |
| Short-Term Debt Issued | - | - | - | - | 15.5 | 2.9 | |
| Total Debt Issued | - | - | - | - | 15.5 | 2.9 | |
| Long-Term Debt Repaid | - | -1.46 | -1.62 | -7.19 | -6.72 | -6.01 | |
| Net Debt Issued (Repaid) | -1.14 | -1.46 | -1.62 | -7.19 | 8.78 | -3.11 | |
| Issuance of Common Stock | - | 15 | - | 25.76 | 0.02 | - | |
| Other Financing Activities | - | - | - | - | 21.5 | - | |
| Financing Cash Flow | -8.23 | 11.54 | -1.62 | 18.57 | 30.3 | -3.11 | |
| Net Cash Flow | -14.08 | 3.91 | -14.42 | 6.71 | 14.99 | -0.65 | |
| Free Cash Flow | -5.85 | -7.63 | -12.8 | -11.86 | -15.31 | 2.46 | |
| Free Cash Flow Growth | - | - | - | - | - | -59.95% | |
| Free Cash Flow Margin | -145.37% | -130.99% | -213.57% | -151.86% | -160.15% | 15.80% | |
| Free Cash Flow Per Share | -0.96 | -3.50 | -6.18 | -10.89 | -28.67 | 10.00 | |
| Cash Interest Paid | 0.36 | 0.54 | 0.6 | 0.42 | 1.19 | 2.04 | |
| Levered Free Cash Flow | -1.97 | -1.39 | -26.93 | -5 | -4.55 | 8.85 | |
| Unlevered Free Cash Flow | -1.64 | -1.05 | -26.56 | -4.78 | -2.69 | 12.83 | |
| Change in Net Working Capital | -3.08 | -1.84 | 23.57 | 1.69 | -1.46 | -18.16 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.